宜明昂科生物医药技术（上海）股份有限公司（股票代码：01541，简称“宜明昂科-B”）于2026年5月7日发布2026年4月股份变动月报。报告显示，公司在2026年4月期间，无新增股份发行、回购、注销或库藏等变动活动，股本整体保持稳定。
根据月报披露，截至2026年4月30日，公司已发行H股420,477,305股，非上市股份11,030,390股，合计注册股本为人民币431,507,695元，较上月无变化。月报并显示，公司已符合香港联合交易所有限公司相关上市规则所要求的公众持股量规定。
公告由执行董事、联席公司秘书关梅签署。公司同时确认，将继续遵守香港联交所《上市规则》及相关法律法规的要求。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.